Log in

Aquabounty Technologies Stock Forecast, Price & News

+0.66 (+14.67 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $5.16
50-Day Range
MA: $3.09
52-Week Range
Now: $5.16
Volume3.54 million shs
Average Volume329,872 shs
Market Capitalization$165.77 million
P/E RatioN/A
Dividend YieldN/A
AquaBounty Technologies, Inc., a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts. AquaBounty Technologies, Inc. is a subsidiary of Intrexon Corporation.
Read More
Aquabounty Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.73 out of 5 stars

Industry, Sector and Symbol

Industry Fishing, hunting & trapping
Current SymbolNASDAQ:AQB



Sales & Book Value

Annual Sales$190,000.00
Book Value$1.10 per share


Net Income$-13,230,000.00


Market Cap$165.77 million
Next Earnings Date11/3/2020 (Estimated)
OptionableNot Optionable
+0.66 (+14.67 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AQB News and Ratings via Email

Sign-up to receive the latest news and ratings for AQB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Aquabounty Technologies (NASDAQ:AQB) Frequently Asked Questions

How has Aquabounty Technologies' stock price been impacted by COVID-19?

Aquabounty Technologies' stock was trading at $1.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AQB stock has increased by 178.9% and is now trading at $5.16.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Aquabounty Technologies?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aquabounty Technologies in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Aquabounty Technologies

When is Aquabounty Technologies' next earnings date?

Aquabounty Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Aquabounty Technologies

How were Aquabounty Technologies' earnings last quarter?

Aquabounty Technologies Inc (NASDAQ:AQB) issued its earnings results on Thursday, August, 6th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.11).
View Aquabounty Technologies' earnings history

What price target have analysts set for AQB?

3 brokers have issued 12 month price targets for Aquabounty Technologies' stock. Their forecasts range from $3.50 to $5.00. On average, they expect Aquabounty Technologies' stock price to reach $4.50 in the next twelve months. This suggests that the stock has a possible downside of 12.8%.
View analysts' price targets for Aquabounty Technologies

Are investors shorting Aquabounty Technologies?

Aquabounty Technologies saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 367,200 shares, a decrease of 11.2% from the August 15th total of 413,400 shares. Based on an average trading volume of 551,300 shares, the short-interest ratio is currently 0.7 days. Currently, 4.8% of the company's stock are short sold.
View Aquabounty Technologies' Short Interest

Who are some of Aquabounty Technologies' key competitors?

What other stocks do shareholders of Aquabounty Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aquabounty Technologies investors own include Precigen (PGEN), Celldex Therapeutics (CLDX), ZIOPHARM Oncology (ZIOP), AbbVie (ABBV), Ocular Therapeutix (OCUL), AT&T (T), Vistagen Therapeutics (VTGN), Allena Pharmaceuticals (ALNA), Crispr Therapeutics (CRSP) and Energy Transfer LP Unit (ET).

Who are Aquabounty Technologies' key executives?

Aquabounty Technologies' management team includes the following people:
  • Mr. David A. Frank, CFO & Treasurer (Age 59)
  • Dr. Ronald L. Stotish, Exec. Director & Chief Technology Officer (Age 70)
  • Mr. Alejandro Rojas, Chief Operating Officer of Aquabounty Farms (Age 57)
  • Ms. Sylvia Wulf, CEO, Pres & Exec. Director (Age 61)
  • Mr. Christopher H. Martin, Gen. Counsel & Company Sec. (Age 53)

What is Aquabounty Technologies' stock symbol?

Aquabounty Technologies trades on the NASDAQ under the ticker symbol "AQB."

Who are Aquabounty Technologies' major shareholders?

Aquabounty Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Epiq Partners LLC (2.03%), Sumitomo Mitsui Trust Holdings Inc. (0.62%), Advisor Group Holdings Inc. (0.47%), UBS Group AG (0.07%), Cambridge Investment Research Advisors Inc. (0.05%) and Raymond James Financial Services Advisors Inc. (0.04%). Company insiders that own Aquabounty Technologies stock include David A Frank, Randal J Kirk and Rick L Sterling.
View institutional ownership trends for Aquabounty Technologies

Which major investors are selling Aquabounty Technologies stock?

AQB stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., UBS Group AG, and Cambridge Investment Research Advisors Inc..
View insider buying and selling activity for Aquabounty Technologies

Which major investors are buying Aquabounty Technologies stock?

AQB stock was acquired by a variety of institutional investors in the last quarter, including Advisor Group Holdings Inc., Epiq Partners LLC, and Raymond James Financial Services Advisors Inc.. Company insiders that have bought Aquabounty Technologies stock in the last two years include David A Frank, Randal J Kirk, and Rick L Sterling.
View insider buying and selling activity for Aquabounty Technologies

How do I buy shares of Aquabounty Technologies?

Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aquabounty Technologies' stock price today?

One share of AQB stock can currently be purchased for approximately $5.16.

How big of a company is Aquabounty Technologies?

Aquabounty Technologies has a market capitalization of $165.77 million and generates $190,000.00 in revenue each year. The company earns $-13,230,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis. Aquabounty Technologies employs 39 workers across the globe.

What is Aquabounty Technologies' official website?

The official website for Aquabounty Technologies is www.aquabounty.com.

How can I contact Aquabounty Technologies?

Aquabounty Technologies' mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company can be reached via phone at 978-648-6000 or via email at [email protected]

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.